We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Low serum iron as a possible risk factor for neuroleptic malignant syndrome.
- Authors
Patil, Bhushan Subhash; Subramanyam, Alka A.; Singh, Shipra L.; Kamath, Ravindra M.
- Abstract
Neuroleptic malignant syndrome (NMS) is a rare, but fatal condition characterized by rigidity, fever, dysautonomia and altered consciousness along with elevated serum creatinine phosphokinase levels and leukocytosis. Treatment of NMS includes symptomatic and specific treatment with drugs like bromocriptine may be given. Risk factors for NMS include dehydration, parenteral antipsychotics and high potency antipsychotics. One of the important, but lesser known risk factors for NMS is low serum iron. Pronounced reduction in serum iron suggests that acute phase reactants do have a role in NMS. The present case report focuses on the importance of low serum iron as a risk factor for NMS.
- Subjects
SERUM; FEVER; DYSAUTONOMIA; CREATININE; ANTIPSYCHOTIC agents
- Publication
International Journal of Applied & Basic Medical Research, 2014, Vol 4, Issue 2, p117
- ISSN
2229-516X
- Publication type
Article
- DOI
10.4103/2229-516X.136800